Tag

Medication Safety

TRHC’s MedWise Risk Score™ Reduces the Odds of Adverse Drug Events, Keeping Patients Safer

Moorestown, NJ, May 27, 2020 – Tabula Rasa HealthCare® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces the journal Pharmacy has published its research article “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”. The research article is a 12-month analysis of medical claims data of 1,965 Program of All-Inclusive Care for the... Read More

TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

Moorestown, NJ, May 19, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital Resource. Developed by TRHC’s Precision Pharmacotherapy Research & Development Institute, the resource provides a comprehensive analysis and clinical reviews of potential treatments and therapies for COVID-19. “There are knowledge gaps surrounding the proposed treatments for COVID-19,” said TRHC Chairman and CEO... Read More

TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists

Moorestown, NJ, May 11, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announces it has signed a Letter of Intent with ASCP, a membership association that represents pharmacists, healthcare professionals and students serving the unique medication needs of older adults. The first of its kind, the strategic collaboration will jointly offer TRHC’s medication safety software, MedWise™, available to the pharmacist membership of ASCP.... Read More

Free Webinar: Important Medication Safety Considerations for COVID-19 Treatment

Join Tabula Rasa HealthCare and Strategic Solutions Network on Thursday, May 7, 2020, at 1 p.m. EDT for a free webinar. Richard O. Schamp, MD, TRHC Chief Medical Officer, Veronique Michaud, BPharm, PhD, TRHC Chief Operating Officer, and Jacques Turgeon, BPharm, PhD, Chief Scientific Officer, will discuss the importance of understanding the risks associated with COVID-19 treatment – especially for vulnerable individuals with several chronic diseases who take multiple medications.   To register for the... Read More

Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar

MOORESTOWN, N.J., April 23, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Strategic Solutions Network, a privately-held business-to-business conference company, will present a free webinar entitled Important Medication Safety Considerations for COVID-19 Treatment on Thursday, May 7, 2020 at 1 p.m. EDT. Participants may register here. The webinar will discuss the importance of understanding the risks associated with COVID-19 treatment risks, particularly... Read More

EPIC Pharmacy Network® Renews Contract with TRHC’s PrescribeWellness ™

MOORESTOWN, N.J., April 7, 2020 — Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today its PrescribeWellness™ technology solutions (“PW”) will continue its partnership with EPIC Pharmacy Network® (EPN), renewing their agreement for an additional three years. EPN is one of the largest, independently owned pharmacy services administration organizations and managed care networks for independent pharmacies in the nation. As part of this contract extension,... Read More

Tabula Rasa HealthCare® Named Principal Distributor of the BioIntelliSense BioSticker™ for Programs of All-Inclusive Care for the Elderly (PACE)

Moorestown, NJ – March 17, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, enters into an agreement with BioIntelliSense to distribute its BioSticker™, the first FDA-cleared, single-use device enabling 30 days of continuous vital sign monitoring. The BioIntelliSense DaaS platform can be applied to a wide range of clinical use cases, including monitoring for the key symptoms associated with COVID-19 . “BioSticker remote monitoring... Read More

Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results

MOORESTOWN, NJ, February 27, 2020 — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced its financial results for the fourth quarter and full year ended December 31, 2019. Full Year 2019 Highlights • Total revenue increased 39% to $284.7 million; • Non-GAAP Adjusted EBITDA increased 29% to $37.9 million; • Non-GAAP Adjusted diluted EPS increased to $0.79 from $0.77; • Product revenue increased 22% to... Read More

Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020

Moorestown, NJ, January 13, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a client retention rate of 99.1% in the PACE (Programs of All-inclusive Care for the Elderly) market to begin 2020. PACE organizations nationwide rely on TRHC’s PACE division, CareVention HealthCare,™ for technology, services, and consulting to optimize outcomes and maintain regulatory compliance. CareVention’s lead offering for PACE providers is medication... Read More